TY - JOUR
T1 - Role of risk stratification by SPECT, PET, and hybrid imaging in guiding management of stable patients with ischaemic heart disease: expert panel of the EANM cardiovascular committee and EACVI
AU - Acampa, Wanda
AU - Gaemperli, Oliver
AU - Gimelli, Alessia
AU - Knaapen, Paul
AU - Schindler, Thomas H.
AU - Verberne, Hein J.
AU - Zellweger, Michael J.
AU - AUTHOR GROUP
AU - Kaufmann, Philipp A.
AU - Rosenhek, Raphael
AU - Haugaa, Kristina H.
AU - Cardim, Nuno
AU - Delgado, Victoria
AU - Camici, Paolo G.
AU - Donal, Erwan
AU - Galderisi, Maurizio
AU - Edvardsen, Thor
AU - Hacker, Markus
PY - 2015
Y1 - 2015
N2 - Risk stratification has become increasingly important in the management of patients with suspected or known ischaemic heart disease (IHD). Recent guidelines recommend that these patients have their care driven by risk assessment. The purpose of this position statement is to summarize current evidence on the value of cardiac single-photon emission computed tomography, positron emission tomography, and hybrid imaging in risk stratifying asymptomatic or symptomatic patients with suspected IHD, patients with stable disease, patients after coronary revascularization, heart failure patients, and specific patient population. In addition, this position statement evaluates the impact of imaging results on clinical decision-making and thereby its role in patient management. The document represents the opinion of the European Association of Nuclear Medicine (EANM) Cardiovascular Committee and of the European Association of Cardiovascular Imaging (EACVI) and intends to stimulate future research in this field
AB - Risk stratification has become increasingly important in the management of patients with suspected or known ischaemic heart disease (IHD). Recent guidelines recommend that these patients have their care driven by risk assessment. The purpose of this position statement is to summarize current evidence on the value of cardiac single-photon emission computed tomography, positron emission tomography, and hybrid imaging in risk stratifying asymptomatic or symptomatic patients with suspected IHD, patients with stable disease, patients after coronary revascularization, heart failure patients, and specific patient population. In addition, this position statement evaluates the impact of imaging results on clinical decision-making and thereby its role in patient management. The document represents the opinion of the European Association of Nuclear Medicine (EANM) Cardiovascular Committee and of the European Association of Cardiovascular Imaging (EACVI) and intends to stimulate future research in this field
U2 - https://doi.org/10.1093/ehjci/jev093
DO - https://doi.org/10.1093/ehjci/jev093
M3 - Article
C2 - 25902767
SN - 2047-2404
VL - 16
SP - 1289
EP - 1298
JO - European heart journal cardiovascular Imaging
JF - European heart journal cardiovascular Imaging
IS - 12
ER -